/Companies

Denovai

Rehovot, IL · 1 known investors

Find your way into Denovai

Sign up to see every warm intro you have to Denovai

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Denovai team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

DenovAI Biotech uses artificial intelligence and computational molecular biophysics to design proteins de novo, building platforms for rapid antibody discovery and bespoke high-affinity binders. The company targets therapeutic and diagnostic applications, including antibodies, peptide biologics, and diagnostic reporters for drug discovery.

Investors · 1

Frequently asked questions

What does Denovai do?
DenovAI Biotech uses artificial intelligence and computational molecular biophysics to design proteins de novo, building platforms for rapid antibody discovery and bespoke high-affinity binders. The company targets therapeutic and diagnostic applications, including antibodies, peptide biologics, and diagnostic reporters for drug discovery.
Who are Denovai's investors?
Denovai's investors include Amiti Ventures.
Where is Denovai headquartered?
Denovai is headquartered in Rehovot, IL.